alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
r CAPITOL BANCORP 

LIMITED 

February 2, 2012 

Capitol Bancorp Center 

••'fDiDT'v^i^KlT Qp 200 Washington Square-North 

-:•i•'\•0;'"'^OT,Vn^M Lansing, Ml 48933 

VANSt-U[J.!AUy. ,^ td. 517.487.6555 

'}XKh T OPERA-IONS fa. 517.374.2575 

Docket Management Facility 

U.S. Department of Transportation 

1200 New Jersey Avenue SE 

West Building Ground Floor, Room W12-140 

Washington, DC 20590 

Ref: Sun Country Slot Exemption - Docket Number FAA-2012-0089 

Ladies and Gentlemen: 

Sun Country Airlines has requested an exemption from the slot limit for Ronald Reagan 

Washington National Airport (DCA) set forth in § 93.123(a), to permit the FAA to create air 

carrier slots during certain limited hours for Sun Country's use. The proposed air carrier slots 

would reptace-two slot exemptions under DOT Order 2010-12-16 awarded to Sun Country. On 

January 6, 2012, the United Stales Court of Appeals for the District of Columbia Circuit vacated 

the DOT Order, and Sun Country will lose its existing service between DCA and Lansing's 

Capital Region International Airport. Specifically. Sun Country desires one daily slot during 

each of the 1000 and 1100 hours. The proposed exemption would permit Sun Country to 

continue operating its existing services and avoid an inequitable result of the Court's order. 

Capitol Bancorp Limited is a multi-bank holding company with operations in eight states 

throughout the United States. We are a heavily regulated industry. The Federal Reserve Board 

(FRB), the Federal Deposit Insurance Corporation (FDIC), the Controller of the Currency and the 

Securities and Exchaiige C6mmission (SEC) are routinely involved in all of our activities, 

consequently, we are required to be in Washington, DC numei^ous times during the course of a 

given year. Failure tO" extend an "cAemplion'to Suri Countr>''s Airlines wil l have a'signit'icani 

negative effect on our ability to operate as a business enterprise. 

The Sun Country DCA service is essential to the economic growth of the Greater Lansing Region. 

The daily service is the only large aircraft (737-800) service to Washington Reagan Airport in the 

state of Michigan outside of Detroit!' Prior to'S'un Co*"untry. the regional cbmnVuhity had requested 

the" introduction of this service" from", numerous other airline operators withouf'success. 

Ac'coVdihgly, it Is critical thai the FAA take "the necessary steps to ensure the continuation of the 

Sun Country slots at the established flight times in support of Greater Lansing's business and 

economic growth. ' " -

Your immediate approval of this exemption, so that Sun Country can begin to enter flight 

schedules fot^ sale for tine b'alance of 2012, will be greatly appreciated. / '^ 

Sincerely,' " ' "' ' • ' ' ' "" "' 

Joseph p.'Reid"' '"" . • • .• 

Chairtrian andCEO ^ •- . . 

vvvvvv.capilolbancorp.com
**EXHIBIT 32.1**

 

**CERTIFICATION PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Annual Report of Elecsys Corporation (the “Company”) on Form 10-KSB for the annual period ended April 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and as of the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge;

 
|   | 1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and |
|--------|----|---------------------------------------------------------------------------------------------------------------------------|

 
|   | 2) | The information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

 
|                                 |   |   |                                                                               |
|--------------------------------------|--------|--------|------------------------------------------------------------------------------------|
| Date:   July 24, 2006 |   |   | /s/ Karl B. Gemperli                                                               |
|                                 |   |   | Karl B. Gemperli

President, Chief Executive Officer (Principal Executive Officer) |

 

 

**[A signed original of this written statement required by Section 906 has been provided to and will be retained by Elecsys Corporation and furnished to the Securities and Exchange Commission or its staff upon request.]**
Exhibit 99.2
                              C.F.O. Certification




                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In  connection  with the  Quarterly  Report of  Crescent  Moon,  Inc.  (Formerly
Cherokee  Investments,  Inc.) on Form  10-QSB for the period  ending  August 31,
2002, as filed with the  Securities  and Exchange  Commission on the date hereof
(the  "Report"),  I,  Robert  Denome,  Chief  Executive  Officer  (acting  Chief
Financial Officer) of the Company,  certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that, to
the best of my knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.




/s/ Robert Denome
Chief Executive Officer
(Acting Chief Financial Officer)
December 30, 2002
**EXHIBIT 23.1**

 

**Consent of Independent Auditors**

 

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-33132, 333-80363, 333-07577) of CROWNFINANCIAL GROUP, INC., formerly M.H. MEYERSON & CO., INC., and in the related Prospectus and in the Registration Statements (Form S-8 Nos. 333-53410, 333-83371) pertaining to the Stock Option Plans of CROWN FINANCIAL GROUP, INC., formerly M.H.MEYERSON & CO., INC., of our report dated March 20, 2003, with respect to the consolidated financial statements of CROWN FINANCIAL GROUP, INC., formerly M.H. MEYERSON & CO., INC., included in this amended Annual Report (Form 10-K/A) for theyear ended January 31, 2003. 

 

*/s/ Sanville& Company*

 

*Abington,Pennsylvania*

*March 9, 2004*
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-6476

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

TOM J. BILLMAN,

Defendant - Appellant.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. J. Frederick Motz, Chief District Judge.

(CR-89-466-JFM, CA-97-2120-JFM)

Submitted: February 9, 1999 Decided: March 4, 1999

Before LUTTIG and WILLIAMS, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Marcia Gail Shein, LAW OFFICE OF MARCIA G. SHEIN, P.C., Atlanta,

Georgia; Charles Ivey Billman, Arlington, Virginia, for Appellant.

Barbara Slaymaker Sale, Assistant United States Attorney, Joyce

Kallam McDonald, Assistant United States Attorney, Baltimore,

Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Tom J. Billman seeks to appeal the district court’s order

denying his motion filed under 28 U.S.C.A. § 2255 (West 1994 &

Supp. 1998). We have reviewed the record and the district court’s

opinion and find no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal. We have carefully considered Billman’s claims of insufficiency of the evidence,

ineffective assistance of counsel, trial error, constructive amendment of the indictment, prosecutorial misconduct, and ineffective

waiver of his right to a jury trial. Finding no merit to any of

these assignments of error, we decline to disturb the district

court’s order dismissing Billman’s motion. We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

DISMISSED
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of AmREIT (the Company) on Form 10-K for the period
ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Chad C. Braun, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1.
    The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and2.
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. /s/ Chad C. Braun Chad C. Braun
Chief Financial Officer
March 31, 2005 36
ex102.htm












Addendum No. 1







Dated March 1, 2016 to that certain consulting agreement originally dated as of the 1st day of September 2015 by and between HCi Viocare, a Nevada corporation, having a registered office at 123 W. Nye Lane, Suite 129, Carson City, NV 89706, U.S.A. (the "Company") and Sergios Katsaros, resident of 8 Kehagia St., Filothei 15237, Greece, (the “Consultant”), hereinafter referred to as the “Agreement”.







In accordance with Item 2. – Term; Subsection 2.1 to the Agreement, the Company hereby extends the Term of the Agreement for a period of one (1) year starting on 01.03.2016 and ending on 28.02.2017.







All other terms and conditions as contained in the Agreement remain in full force and effect.


 


This Addendum No. 1 shall be appended to and form a part of the Agreement.


 



	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.


















	
 


The Company 


 


/s/Sotirios Leontaritis


HCi Viocare


By its President


Sotirios Leontaritis


 


 

	
 


The Consultant


 


 


/s/Sergios Katsaros


Sergios Katsaros
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                       4,479,753
<SECURITIES>                                         0
<RECEIVABLES>                              768,579,808
<ALLOWANCES>                                29,977,571
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       2,570,779
<DEPRECIATION>                               1,703,080
<TOTAL-ASSETS>                             575,986,635
<CURRENT-LIABILITIES>                                0
<BONDS>                                    433,733,940
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                 105,566,351
<TOTAL-LIABILITY-AND-EQUITY>               575,986,635
<SALES>                                              0
<TOTAL-REVENUES>                            70,006,432
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                             8,024,205
<INTEREST-EXPENSE>                          27,625,662
<INCOME-PRETAX>                             18,158,342
<INCOME-TAX>                                 7,755,531
<INCOME-CONTINUING>                         10,402,811
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                10,402,811
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
### **CHAPTER 16A—ATLANTIC TUNAS CONVENTION**

Sec.
971.
Definitions.
971a.
Commissioners.
971b.
Advisory committee.
971b–1.
Species working groups.
971c.
Authority of Secretary of State; cooperative enforcement agreements.
971d.
Administration.
971e.
Violations.
971f.
Enforcement.
971g.
Cooperation in carrying out Convention.
971h.
Authorization of appropriations.
971i.
Research on Atlantic highly migratory species.
971j.
Repealed.
971k.
Savings clause.
UAS/UAV Aircraft Pre-Flight Check List 

. 

Ensure that all parts and functions of UAV aircraft are in working condition. 

. 

Ensure that the remote controller, battery, and mobile device for controlling 

Phantom are fully charged. 

. 

Ensure that there is no foreign objects stuck in lens, micro sd card is inside 

camera, gimbal can rotate freely before powering on. 

. 

Ensure propellers are securely mounted and motors are starting functionally and 

normally. 

. 

Ensure signal to remote and UAV is connected and stable. Ensure auto return 

home flight is configured in event of loss of signal. 

. 

Calibrate compass and GPS for proposed flight. 

. 

Map proposed flight, parameters of flight, outline ideal flight trajectory and map 

out positions before flight. 
. 

Ensure DJI app, aircraft and controller firmware is updated to the latest version. 

. 

Ensure flight area is outside of no fly zones, in a permitted area. Check weather 

and wind conditions for permissible flight. 

. 

Observe local regulations, obtain appropriate authorization, and understand risks 

of flight.
SERVED FEBRUARY 1, 2010 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF HEARINGS 

WASHINGTON, DC ' 

IN THE MATTER OF 

GREAT LAKES AVIATION, INC. 

FAA DOCKET NO. CP09WP0008 

(Civil Penalty Action) 

DMS NO. FAA-2009-0103 

AMENDED HEARING NOTICE 

NOTICE IS HEREBY GIVEN that testimony and evidence will be heard and considered 

on March 30,31 and April 1,2010, in the U.S. Tax Court, Courtroom C502, Byron 

G. Rogers U.S. Courthouse, 1929 Stout Street, Denver, CO 80294. Hearings will 

commence at 9:00 a.m. and conclude at 4:30 p.m. each day. The parties should vacate 

the courthouse on or before 5:00 p.m. each day. 

Settled cases will not be removed from the docket until the Judge receives the 

proper pleading(s). Pleadings may be forwarded by fax, express mail, courier or 

postal service. 

SO ORDERED. 

Richard U. Uaodwin 

U.S. Administrative Law Judge^ 

Attachment - Service List 
FAA Docket No. CP09NM0008 

(Civil Penalty Action) 

SERVICE LIST 

ORIGINAL & ONE COPY 

Federal Aviation Administration 

800 Independence Avenue, S.W. 

Washington, DC 20591 

Attention: Hearing Docket Clerk, AGC-430 

Wilbur Wright Building—Suite 2W1000' 

ONE COPY 

Timothy R. Thornton, Respondent's Counsel 

Briggs and Morgan, P.A. 

2200 IDS Center 

80 South 8th Street 

Minneapolis, MN 55402-2157 

TEL: 612-977-8400 

FAX: 612-977-8650 

R. Scott Morris, Complainant's Counsel 

Northwest Mountain Region, ANM-7 

Federal Aviation Administration 

1601 Lind Avenue, SW. 

Renton, WA 98057 

TEL: 425-227-2007 

FAX: 425-227-1007 

The Honorable Richard C. Goodwin, Administrative Law Judge 

Office of Hearings, M-20 

U.S. Department of Transportation 

1200 New Jersey Avenue, S.E. 

East Building Ground Floor, Room El2-320 

Washington, DC 20590 

TEL: 202-366-2139 Attorney-Advisor 

202-366-5121 Legal Assistant 

FAX: 202-366-7536 

' Service was by U.S. Mail. For service in person or by expedited courier, use the following address: 

Federal Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building—Suite 

2W1000, Washington, DC 20591; Attention: Hearing Docket Clerk, AGC-430.
### SUBCHAPTER CIV—KLAMATH RIVER CONSERVATION AREA
**EXHIBIT 31.1**
**CERTIFICATIONS**
I, J. William Freytag, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Myogen, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement ofa material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements weremade, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and
c) disclosed in this report any change in the registrant’s internal controlover financial reporting that occurred during the registrant’s most recentfiscal quarter (the registrant’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors or (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process,summarize and report financial information; and
b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.   Date: December 4, 2003    /s/ J. William Freytag    J. William FreytagPresident, Chief Executive Officer and Chairman(Principal Executive Officer)
# C_2011139EN.01001301.xml

| 7.5.2011 | EN | Official Journal of the European Union | C 139/13 |
| --- | --- | --- | --- |

7.5.2011

EN

Official Journal of the European Union

C 139/13

---

Reference for a preliminary ruling from the Tribunal Supremo (Spain) lodged on 7 February 2011 — Vodafone España, S.A. v Ayuntamiento de Tudela

(Case C-57/11)

2011/C 139/23

Language of the case: Spanish

Referring court

Referring court

Tribunal Supremo

Parties to the main proceedings

Parties to the main proceedings

Appellant: Vodafone España, S.A.

Appellant:

Respondent: Ayuntamiento de Tudela

Respondent:

Questions referred

Questions referred

| 1. | Must Article 13 of Directive 2002/20/EC (1) of the European Parliament and of the Council of 7 March 2002 on the authorisation of electronic communications networks and services (Authorisation Directive) be interpreted as precluding national legislation under which a fee may be required for the right to install facilities on municipal public land from operating undertakings which, without being proprietors of the network, use it to provide mobile telephony services? |
| --- | --- |

1.

Must Article 13 of Directive 2002/20/EC (1) of the European Parliament and of the Council of 7 March 2002 on the authorisation of electronic communications networks and services (Authorisation Directive) be interpreted as precluding national legislation under which a fee may be required for the right to install facilities on municipal public land from operating undertakings which, without being proprietors of the network, use it to provide mobile telephony services?

1

| 2. | In the event that the levy is found to be compatible with Article 13 of Directive 2002/20/EC, do the conditions in accordance with which the fee is required under the contested local regulation satisfy the requirements of objectivity, proportionality and non-discrimination laid down in that provision, together with the need to ensure the optimal use of the resources concerned? |
| --- | --- |

2.

In the event that the levy is found to be compatible with Article 13 of Directive 2002/20/EC, do the conditions in accordance with which the fee is required under the contested local regulation satisfy the requirements of objectivity, proportionality and non-discrimination laid down in that provision, together with the need to ensure the optimal use of the resources concerned?

| 3. | Is it appropriate to recognise Article 13 of Directive 2002/20/EC as having direct effect? |
| --- | --- |

3.

Is it appropriate to recognise Article 13 of Directive 2002/20/EC as having direct effect?

---

(1)  OJ L 108, p. 21

1

---
777 Old Saw Mill River Road

Tarrytown, New York 10591



(914) 789-2800

www.progenics.com 
 Contact:
Kathleen Fredriksen

Corporate Development

(914) 789-2871

kfredriksen@progenics.com 
  th
 
  Progenics Pharmaceuticals, Inc. develops innovative medicines for oncology, and has a pipeline that includes product candidates in preclinical through late-stage development. Progenics' first commercial product, Relistor ® (methylnaltrexone bromide) for opioid-induced constipation, is marketed and in further development by Salix Pharmaceuticals, Ltd. for markets worldwide other than Japan, where Ono Pharmaceutical Co., Ltd. is developing the subcutaneous formulation. For additional information, please visit www.progenics.com .
### SUBCHAPTER LIX–ZZ—RECONSTRUCTION ERA NATIONAL HISTORICAL PARK